International Patent: PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF NEONATAL BRONCHOPULMONARY DYSPLASIA, COMPRISING MIR-203A-3P AS ACTIVE INGREDIENT

GENEVA, Oct. 5 -- SAMSUNG LIFE PUBLIC WELFARE FOUNDATION filed a patent application (KR2026/003756) for “PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF NEONATAL BRONCHOPULMONARY DYSPLASIA, COMPRISING MIR-203A-3P AS ACTIVE INGREDIENT”. With publication no. WO/2026/205828, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/7105

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....